Bromantane has no prohypoxic activity." "The use of the drug, in contrast to the action of a typical psychostimulant, is not associated with the phenomenon of hyperstimulation and causes no consequences such as functional exhaustion of the body." "Bromantane administration in therapeutic doses is characterized by the almost full absence of side effects including manifestations of withdrawal syndrome and hyperstimulation." "[Bromantane] has low peripheral sympathomimetic effects
doi: 10.3389/fragi.2022.852569 Received 11 January 2022 Accepted 08 February 2022 Published 07 March 2022 Volume 3 - 2022 Edited by Guillermo Lopez Lluch, Universidad Pablo de Olavide, Spain Reviewed by Robert Pazdro, University of Georgia, United States Usha Mishra, University of Birmingham, United Kingdom Updates Copyright 2022 Lizzo, Migliavacca, Lamers, Frzal, Corthesy, Vinyes-Pars, Bosco, Karagounis, Hvelmann, Heise, von Eynatten and Gut
Long-term data suggest that routine laboratory monitoring may not be necessary during deucravacitinib treatment (Korman et al
ChiurchiVMaccarroneM
